Skip to main content

Immunological Aspects of the Toxic Oil Syndrome

  • Conference paper
Applied Toxicology: Approaches Through Basic Science

Abstract

The Toxic Oil Syndrome (TOS), which occurred in Spain in 1981, was caused by the ingestion of rapeseed oil denatured with 2% aniline, sold illegally as edible oil. The number of unaffected individuals exposed to the toxic oil is unknown, but more than 20,000 people suffered from the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aguilera B (1989) Lesiones vasculares en el Síndrome Tóxico por aceite de colza. Doctoral Thesis, Madrid Universidad Autónoma 26–41.

    Google Scholar 

  • Bell SA, Hobbs MV, Rubin RL (1992) Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J. Immunol. 148: 3369–3376.

    PubMed  CAS  Google Scholar 

  • Blasco R, Ruiz-Gutierrez V (1992) Effect of fatty acid anilides on immune responses of Swiss mice. Clin. Exp. Immunol. 89: 131–135.

    Article  PubMed  CAS  Google Scholar 

  • De Andrés B, del Pozo V, Gallardo S, de Arruda-Chaves E, Cárdaba B, Martin-Orozco E, Posada M, Palomino P, Lahoz C (1995) Improved method for mRNA extraction from paraffin-embedded tissues. Biotechniques 18(1): 42–43.

    PubMed  Google Scholar 

  • Gallardo S, del Pozo V, Cárdaba B, de Andrés B, Martin-Orozco E, Fernandez JC, Tramón P, Posada M, Abaitua I, Palomino P, Lahoz C (1994) Immunological basis of toxic oil syndrome (TOS). Toxicology 93:289–299.

    Article  PubMed  CAS  Google Scholar 

  • Gleichmann H, Gleichman E (1984) GVHD a model for the Spanish Toxic Oil Syndrome. Lancet, i: 1174–1175.

    Google Scholar 

  • Goldman M, Druet P, Gleichmann E (1991) Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12(7): 223–227.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson D I (1988) Elevated levels of soluble IL-2 receptors in Multiple Sclerosis. New Eng. J. Med. 319:1019–1020.

    PubMed  CAS  Google Scholar 

  • Kammüller M E, Penninks A H, Seinen W (1984) Spanish Toxic Oil Syndrome is a chemically induced graft-versus-host-like epidemic. Lancet, i: 1174–1175.

    Article  Google Scholar 

  • Kammüller M E, Bloksma N, Seinen W (1988) Chemically induced autoimmune reactions and Spanish toxic oil Syndrome. Focus on hydantoins and related compounds. J. Toxicol. 26:157–174.

    Google Scholar 

  • Kammüller ME., Bloksma N, Seinen W. (1989) Autoimmunity and toxicology. Immune dysregulation induced by drugs and chemicals. In: Kammüller M.E., Bloksma, N. and Seinen, W. (eds), Autoimmunity and toxicology. Immune dysregulation induced by drugs and chemicals. Elsevier, Amsterdam, pp 4–34.

    Google Scholar 

  • Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM (1991) Functional subsets of allergen-reactive human CD4+ T cells. Immunol. Today 12(11): 392–395.

    Article  PubMed  CAS  Google Scholar 

  • Kapsenberg ML, Jansen HM, Bos JD, Wierenga E A (1992) Role of type 1 and type 2 T helper cells in allergic diseases. Curr. Opin. Immunol. 4: 788–793.

    Article  PubMed  CAS  Google Scholar 

  • Kaufman LD, Gruber BL, Gómez-Reino JJ, Miller F (1994) Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome. Arch. Dermatol 130: 41–47.

    Article  PubMed  CAS  Google Scholar 

  • Kilbourne EM (1983) Clinical epidemiology of toxic oil syndrome. New. Engl. J. Med. 309: 1408–1414.

    Article  PubMed  CAS  Google Scholar 

  • Kilbourne EM, Bernert JT, Posada M et al. (1988) Chemical correlates of the pathogenicity of oils related to the TOS epidemic in Spain. Am. J. Epidemiol. 127: 1210–1227.

    PubMed  CAS  Google Scholar 

  • Kilbourne EM, Posada M, Abaitua I, et al. (1991) Toxic Oil Syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. J. Am. Coll. Cardiol. 18: 711–717.

    Article  PubMed  CAS  Google Scholar 

  • Lahoz C, Tricas L, Vela C, Lauzurica P, Gurbindo C, Garcia R (1983) Hyper IgE, eosinophilia and immunological hyperreactivity due to ingestion of adultered rapeseed oil (Toxic Oil Syndrome). Eur. J. Respir. Dis. 62: 415–418.

    Google Scholar 

  • Lahoz C, Rose NR, Robinson CJG (1992) Immunology. In: Nadal, J and Tarkowski, S (Eds), “Toxic Oil Syndrome: current Knowledge and future perspectives”. WHO Regional Publications, European series, no 42, pp. 143–152.

    Google Scholar 

  • Lassalle P, Sergant M, Delneste Y, et al. (1991) Levels of soluble IL-2 receptor in plasma from asthmatics. Correlation blood eosinophilia, lung functions, and corticosteroid therapy. Clin. exp. Immunol. 87: 266–271.

    Article  Google Scholar 

  • Martínez Tello FJ, Téllez Y (1992) Pathology In: Nadal, J. and Tarkowski, S. (Eds), “Toxic Oil Syndrome: current Knowledge and future perspectives”. WHO Regional Publications, European series, no 42, pp. 39–65.

    Google Scholar 

  • Manoussakis MN, Papadoppulos GK, Drosos AA, Motsopoulos HM (1989) Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune disease. Clin. Immunol. Immunopathol. 50:321–32.

    Article  PubMed  CAS  Google Scholar 

  • Mayeno AN, Belongia EA, Fengling Lundu SK, Gleich GJ (1992) 3-(Phenyl-amino) alanine, a novel aniline-derived aminoacid associated with the Eosinophilia-Myalgia Syndrome: a link to the Toxic Oil Syndrome?. Mayo Clin. Proc. 67:1134–1139.

    PubMed  CAS  Google Scholar 

  • McKinley KL, Harati Y, Schneider LW (1993) Chronic immune activation in the eosinophilia-myalgia syndrome. Muscle & Nerve 16: 947–951.

    Article  CAS  Google Scholar 

  • Romagnani S. (1991) Human Th1 and Th2 subsets: doubt no more. Immunol. Today. 12(8): 256–257.

    Article  PubMed  CAS  Google Scholar 

  • Scott P, Kaufmann HE (1991) The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today. 12(10): 346–348.

    Article  PubMed  CAS  Google Scholar 

  • Silverman ED, Laxer R, Nelson DL, Rubin L A (1991) Soluble interleukin 2 receptor in juvenile rheumatoid arthritis. J. Rheumatol. 18: 1398–1402.

    PubMed  CAS  Google Scholar 

  • Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okomura K, Hirose S (1989) Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Annals of Rheumatic Diseases 48: 803–809.

    Article  CAS  Google Scholar 

  • Tricas, L. (1984) “Immunological hyperreactivity in the acute phase of TOS” Doctoral Thesis, University of Zaragoza.

    Google Scholar 

  • WHO (1991) “Toxic oil syndrome and eosinophilia-myalgia syndrome. Pursuing parallels in pathogenesis”. Report on a WHO meeting, Washington, DC., WHO Regional Office for Europe, Copenhagen, 22 pp.

    Google Scholar 

  • WHO (1992) “Toxic oil syndrome and eosinophilia-myalgia syndrome. Clinical aspects”. Report on a workshop. Stony Brook, New York. WHO Regional Office for Europe, Copenhagen, 19 pp.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lahoz, C. et al. (1997). Immunological Aspects of the Toxic Oil Syndrome. In: Seiler, J.P., Vilanova, E. (eds) Applied Toxicology: Approaches Through Basic Science. Archives of Toxicology, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60682-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60682-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64505-1

  • Online ISBN: 978-3-642-60682-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics